XML 24 R12.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK OPTIONS AND WARRANTS
9 Months Ended
Mar. 31, 2021
Disclosure Text Block Supplement [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]

NOTE 6 – STOCK OPTIONS AND WARRANTS

 

On July 22, 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”) which contains provisions for up to 5,000,000 stock-based instruments to be granted to employees, consultants and directors.

 

Effective September 24, 2020, the Company filed a withdrawal of designation related to the 2013 Series Convertible Preferred Stock designation. In doing so, the State of Nevada also withdrew all preferred shares authorized. The Company will file a new designation authorizing preferred shares should this be needed in the future.

 

No options have been granted as of March 31, 2021 or in fiscal year 2021.  

 

A summary of the status of our outstanding stock options as of March 31, 2021 and June 30, 2020 and changes during the periods then ended is presented below:

 

   

March 31, 2021

   

June 30, 2020

 
           

Weight Average

   

Intrinsic

           

Weight Average

   

Intrinsic

 
   

Shares

   

Exercise Price

   

Value

   

Shares

   

Exercise Price

   

Value

 

Outstanding beginning of period

    2,870,000     $ 0.12               3,970,000     $ 0.12          

Granted

    -     $ 0.00               -     $ 0.00          

Expired/Cancelled

    (1,840,000

)

  $ (0.12

)

            (1,100,000

)

  $ (0.14

)

       

Exercised

    -     $ 0.00               -     $ 0.00          

Outstanding end of period

    1,030,000     $ 0.12     $ -       2,870,000     $ 0.12     $ -  

Exercisable

    1,030,000     $ 0.12     $ -       2,870,000     $ 0.12     $ -  

 

The following table summarizes the range of outstanding and exercisable options as of March 31, 2021:

 

       

Outstanding

   

Exercisable

 

Range of

Exercise Prices

   

Number Outstanding

at

March 31, 2021

   

Weighted

Average

Remaining

Contractual Life

   

Weighted

Average

Exercise Price

   

Number

Exercisable at

March 31, 2021

   

Weighted

Average Remaining

Contractual Life

 
$ 0.08       150,000       0.67     $ 0.08       150,000       0.67  
$ 0.10       480,000       0.75     $ 0.10       480,000       0.75  
$ 0.17       400,000       0.67     $ 0.17       400,000       0.67  
          1,030,000                       1,030,000